Evidence map›Paper›PMID 41084532›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2025

A Single Centre Retrospective Cohort Analysis of HIV Associated Lymphoma from Northern India.

Arihant Jain, Sarthak Wadhera, Rudra Narayan Swain, Urmimala Bhattacharjee, Charanpreet Singh, Nishant Jindal, Aditya Jandial, Deepesh Lad, Alka Khadwal, Amanjit Bal and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Arihant JainDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Sarthak WadheraDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Rudra Narayan SwainDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Urmimala BhattacharjeeDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Charanpreet SinghDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Nishant JindalDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Aditya JandialDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Deepesh LadDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Alka KhadwalDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Amanjit BalDepartment of Histopathology, PGIMER Chandigarh, Chandigarh, India.
Reena DasDepartement of Hematology, PGIMER Chandigarh, Chandigarh, India.
Thenmozhi ManiDepartment of Biostatistics, CMC, Vellore, India.
Pankaj MalhotraDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.
Gaurav PrakashDepartment of Clinical Hematology and Medical Oncology, PGIMER - Postgraduate Institute of Medical Education and Research Chandigarh, Chandigarh, 160012 India.ORCID 0000-0003-4142-1592

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The year 2024 marks the 20th year since when free cART was introduced in India. This study reports the clinicopathologic profile and outcomes of people living with HIV (PLHIV) who were diagnosed with lymphoma from Northern India. We also review the outcomes of HIV-associated lymphoma in India reported over the past 2 decades. This study included all PLHIV of age ≥ 12 years who were diagnosed with lymphoma and treated at our center between June 2009 and June 2022. Demographic profile, lymphoma subtype, stage and CD4 count at lymphoma diagnosis, and treatment outcomes were analysed. Forty-eight PLHIV patients were diagnosed with lymphoma during the study period of which 31(64.5%) were diagnosed with AIDS Defining Lymphoma (ADL) while 17 (35.4%) were diagnosed with Non-AIDS Defining Lymphoma. Extra-nodal disease was more common in ADLs as compared to NADLs (87% vs. 23%; Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-024-01927-3.

Indexed as

Anti-retroviral therapyHIVIndiaLymphoma

Identifiers

PMID41084532
PMCPMC12515168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.